DexCom (DXCM) Misses Q4 EPS by 17c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $76.35 +1.85%
EPS Growth %: +27.1%
Financial Fact:
Selling, general and administrative: 75.7M
Today's EPS Names:
CCEL, MHGU, PLG, More
EPS Growth %: +27.1%
Financial Fact:
Selling, general and administrative: 75.7M
Today's EPS Names:
CCEL, MHGU, PLG, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.68, $0.17 worse than the analyst estimate of $0.85. Revenue for the quarter came in at $698.2 million versus the consensus estimate of $696.47 million.
GUIDANCE:
DexCom sees FY2022 revenue of $2.82-2.94 billion, versus the consensus of $2.96 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
- JPMorgan Starts Hyundai Department Store (069960:KS) at Overweight
- Health Canada authorizes Dexcom G7 15 Day CGM for Canadian adults
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
